Dehydroepiandrosterone sulfate sodium | |
---|---|
Trade Name | |
Orphan Indication | Serious burns requiring hospitalization |
USA Market Approval | USA |
USA Designation Date | 1997-01-29 00:00:00 |
Sponsor | Pharmadigm, Inc.;2401 Foothill Drive;Salt Lake City, Utah, 84109 |